Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
23 pending office actions • 17 art units • 23 examiners • 0 of 23 (0%) have an AI response strategy ready • 23 patents granted in the last 365 days
Wayne State University manages a portfolio with 21 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are handled by 21 distinct examiners, showing a ratio of 1 examiner for every 1 action. The portfolio is distributed across 15 distinct art units, reflecting a broad range of biological and pharmaceutical research topics. This wide distribution across 15 art units suggests that the university's research output is technically diverse and categorized into many specialized groups at the USPTO.
The busiest examiner for the university is ZHANG, LEI, who is responsible for 1 busiest examiner pending action. This indicates a highly decentralized prosecution environment where no single examiner holds a significant portion of the workload. Practitioners must manage 21 different individual examiner relationships and navigate the standards of 15 different art units. The diversity of art units highlights the wide-reaching nature of the university's scientific innovations. This decentralized structure requires a versatile prosecution strategy to address the varying expectations of a large group of 21 examiners while maintaining progress on the 21 pending actions.
Based on the USPTO statutory response window for each pending office action. 11 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 11 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (9%) |
| §103 only | 7 (30%) |
| §102 only | 1 (4%) |
| Double-patenting + other | 1 (4%) |
| Multi-statute (no §101) | 12 (52%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZHANG, LEI | 1 | 15.4% | +100.0% |
| HOUGH, JESSANDRA F | 1 | 45.6% | +35.8% |
| CABRAL, ROBERT S | 1 | 62.6% | +32.5% |
| PARENDO, KEVIN A | 1 | 72.2% | +11.5% |
| GAMBETTA, KELLY M | 1 | 71.8% | +33.1% |
| PHAM, KATHERINE-PH MINH | 1 | 59.0% | +50.4% |
| MACH, ANDRE | 1 | 44.9% | +51.7% |
| HAN, SETH | 1 | 59.6% | +28.8% |
| MCCLURE, CHRISTINA D | 1 | 29.9% | +32.7% |
| GASSEN, CHRISTOPHER J | 1 | 79.6% | +25.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18144382 | IN VIVO IMMUNOIMAGING OF INTERFERON-GAMMA | SHOMER, ISAAC | 91d overdue |
| 17862825 | METHODS AND COMPOSITIONS RELATING TO HOT-START, ONE-STEP, REVERSE TRANSCRIPTION-COUPLED PCR | CHANDRA, GYAN | 44d overdue |
| 18100800 | MOLYBDENUM-DAD PRECURSORS FOR DEPOSITION OF MOLYBDENUM FILMS | TUROCY, DAVID P | 8d |
| 17434692 | INDUCTION OF HIGHLY EFFICACIOUS ANTI-TUMOR AND IMMUNE MODULATING ACTIVITY: CELL-FREE OFF THE SHELF THERAPEUTIC MODALITY | BUTTICE, AUDREY L | 34d |
| 18858953 | METHOD AND APPARATUS FOR MAGNETIC RESONANCE (MR) CONTRAST AGENTS | ZHANG, LEI | 69d |
| 18252416 | COMPOSITIONS AND METHODS FOR INHIBITION OF TISSUE ADHESION | WASHVILLE, JEFFREY D | 84d |
| 18910860 | DEVICE AND METHOD FOR DETECTING ORTHOSTATIC VITAL SIGNS | HOUGH, JESSANDRA F | — |
| 18755249 | METHODS OF FORMING STACKED INTEGRATED CIRCUITS USING SELECTIVE THERMAL ATOMIC LAYER DEPOSITION ON CONDUCTIVE CONTACTS AND STRUCTURES FORMED USING THE SAME | PARENDO, KEVIN A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18690227 | VENTRICULAR CATHETERS AND OTHER EMBODIMENTS | HAN, SETH | 24d overdue |
| 18690225 | SOLID STATE SHUNT VALVE WITH ACTIVE OUTFLOW REGULATOR, VENTRICULAR CATHETERS, AND OTHER EMBODIMENTS | PHAM, KATHERINE-PH MINH | 27d |
| 18858953 | METHOD AND APPARATUS FOR MAGNETIC RESONANCE (MR) CONTRAST AGENTS | ZHANG, LEI | 69d |
| 18910860 | DEVICE AND METHOD FOR DETECTING ORTHOSTATIC VITAL SIGNS | HOUGH, JESSANDRA F | — |
| 18780262 | METHOD OF TREATMENT FOR SOLID TUMORS CONTAINING HYPOXIA AND/OR STROMA FEATURES | CABRAL, ROBERT S | — |
| 18755249 | METHODS OF FORMING STACKED INTEGRATED CIRCUITS USING SELECTIVE THERMAL ATOMIC LAYER DEPOSITION ON CONDUCTIVE CONTACTS AND STRUCTURES FORMED USING THE SAME | PARENDO, KEVIN A | — |
| 18601338 | INHERENTLY SELECTIVE THERMAL ATOMIC LAYER DEPOSITION OF COPPER METAL FILMS | GAMBETTA, KELLY M | — |
| 18690241 | METHODS AND COMPOSITIONS TO REDUCE CELLULAR DEPOSITION, AND HYDROCEPHALUS SHUNT FAILURE | MACH, ANDRE | — |
| Art Unit | Apps |
|---|---|
| 1718 | 3 |
| 3781 | 2 |
| 3798 | 1 |
| 1615 | 1 |
| 2881 | 1 |
| 1787 | 1 |
| 1766 | 1 |
| 1612 | 1 |
| 1633 | 1 |
| 1752 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18858953 | METHOD AND APPARATUS FOR MAGNETIC RESONANCE (MR) CONTRAST AGENTS | ZHANG, LEI | 3798 | §103 | Final Rejection | 69d | Pending | Oct 22, 2024 |
| 18910860 | DEVICE AND METHOD FOR DETECTING ORTHOSTATIC VITAL SIGNS | HOUGH, JESSANDRA F | — | §101§103§112 | Non-Final OA | — | Pending | Oct 09, 2024 |
| 18780262 | METHOD OF TREATMENT FOR SOLID TUMORS CONTAINING HYPOXIA AND/OR STROMA FEATURES | CABRAL, ROBERT S | — | §112DP | Non-Final OA | — | Pending | Jul 22, 2024 |
| 18755249 | METHODS OF FORMING STACKED INTEGRATED CIRCUITS USING SELECTIVE THERMAL ATOMIC LAYER DEPOSITION ON CONDUCTIVE CONTACTS AND STRUCTURES FORMED USING THE SAME | PARENDO, KEVIN A | — | §102§103§112 | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18601338 | INHERENTLY SELECTIVE THERMAL ATOMIC LAYER DEPOSITION OF COPPER METAL FILMS | GAMBETTA, KELLY M | 1718 | §102§103 | Final Rejection | — | Pending | Mar 11, 2024 |
| 18690225 | SOLID STATE SHUNT VALVE WITH ACTIVE OUTFLOW REGULATOR, VENTRICULAR CATHETERS, AND OTHER EMBODIMENTS | PHAM, KATHERINE-PH MINH | 3781 | §103 | Final Rejection | 27d | Pending | Mar 07, 2024 |
| 18690241 | METHODS AND COMPOSITIONS TO REDUCE CELLULAR DEPOSITION, AND HYDROCEPHALUS SHUNT FAILURE | MACH, ANDRE | 1615 | §102§103 | Non-Final OA | — | Pending | Mar 07, 2024 |
| 18690227 | VENTRICULAR CATHETERS AND OTHER EMBODIMENTS | HAN, SETH | 3781 | §103 | Final Rejection | 24d overdue | Pending | Mar 07, 2024 |
| 18438175 | ATOMIC LAYER DEPOSITION OF GROUP FIFTEEN MATERIALS | MCCLURE, CHRISTINA D | 1718 | §103 | Final Rejection | — | Pending | Feb 09, 2024 |
| 18409972 | Systems, Methods and Computer Program Products for Charging Autonomous Wireless Sensors in Subsurface Environments | GASSEN, CHRISTOPHER J | 2881 | §103§112 | Final Rejection | — | Pending | Jan 11, 2024 |
| 18238648 | HIGH TEMPERATURE LITHIUM-ION BATTERY AND METHOD OF MAKING SAME | BROWN, MADISON ELIZABETH | 1787 | §102§103§112 | Non-Final OA | — | Pending | Aug 28, 2023 |
| 18252416 | COMPOSITIONS AND METHODS FOR INHIBITION OF TISSUE ADHESION | WASHVILLE, JEFFREY D | 1766 | §103§112 | Non-Final OA | 84d | Pending | May 10, 2023 |
| 18144382 | IN VIVO IMMUNOIMAGING OF INTERFERON-GAMMA | SHOMER, ISAAC | 1612 | §102§103§112 | Final Rejection | 91d overdue | Pending | May 08, 2023 |
| 18135836 | Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling Molecule | ARON, KIMBERLY A | 1633 | §102§103§112 | Final Rejection | — | Pending | Apr 18, 2023 |
| 18100800 | MOLYBDENUM-DAD PRECURSORS FOR DEPOSITION OF MOLYBDENUM FILMS | TUROCY, DAVID P | 1718 | §103§112 | Final Rejection | 8d | Pending | Jan 24, 2023 |
| 18085879 | RECHARGEABLE BATTERIES USING IONIC LIQUID BASED ELECTROLYTES | SMITH, NICHOLAS A | 1752 | §102§103§112 | Final Rejection | — | Pending | Dec 21, 2022 |
| 17970758 | SYSTEM AND METHOD FOR PREDICTING MACHINE FAILURE | NYAMOGO, JOSEPH A | 2858 | §103 | Final Rejection | 6d | Pending | Oct 21, 2022 |
| 18045126 | DECELLULARIZED VASCULAR GRAFTS, METHODS, AND BENCH-TOP MODELS OF ATHEROSCLEROSIS | MARTIN, PAUL C | 1653 | §102 | Final Rejection | 91d overdue | Pending | Oct 07, 2022 |
| 17930042 | AMPHIPHILIC OLIGODEOXYNUCLEOTIDE CONJUGATES AS ADJUVANT ENHANCERS | CHONG, KIMBERLY | 1636 | §102§103§112 | Final Rejection | — | Pending | Sep 06, 2022 |
| 17862825 | METHODS AND COMPOSITIONS RELATING TO HOT-START, ONE-STEP, REVERSE TRANSCRIPTION-COUPLED PCR | CHANDRA, GYAN | 1674 | §101§103 | Final Rejection | 44d overdue | Pending | Jul 12, 2022 |
| 17636107 | IN VIVO IMMUNOIMAGING OF INTERLEUKIN-12 | YOUNG, MICAH PAUL | 1618 | §103 | Final Rejection | 12d | Pending | Feb 17, 2022 |
| 17434692 | INDUCTION OF HIGHLY EFFICACIOUS ANTI-TUMOR AND IMMUNE MODULATING ACTIVITY: CELL-FREE OFF THE SHELF THERAPEUTIC MODALITY | BUTTICE, AUDREY L | 1647 | §103§112 | Final Rejection | 34d | Pending | Aug 27, 2021 |
| 16826010 | ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAME | RYAN, DOUGLAS CHARLES | 1635 | §103 | Non-Final OA | — | Pending | Mar 20, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial